Fill out the brief form below for access to the free report.
Series on Health, Equity, and Women’s Cancers Published in The Lancet Draws Global Attention to Cervical and Breast Cancer
Cervical and breast cancers are the common-most cancers among women living in low-income and middle-income countries (LMICs) but remain severely under-resourced, under-researched and their effects under-publicized. A series of papers published this week in The Lancet, and released at the UICC World Cancer Congress in Paris, France, draws attention to the global burden of breast and cervical cancer, giving stark focus to the burden of these diseases in LMICs.
The authors estimate that if efforts are not amplified, the number of women diagnosed with breast cancer worldwide could nearly double per year to 3.2 million new cases per year in 2030. That’s compared with 1.7 million new cases in 2012, and the number of women diagnosed with cervical cancer per year could increase by 32 percent, from 530,000 new cases per year in 2012, to 700,000 per year in 2030 if incidence rates do not change.
While evidence shows that prevention, screening and treatment services, coupled with awareness-raising, advocacy and education have reduced incidence and mortality of breast and cervical cancer in high-income countries, more needs to be done in LMICs. Although there are cost-effective prevention, screening and treatment options available, inequity in access to care is widespread.
In addition to providing direct cancer care services to women, the authors call for targeted policy responses, both at a national and international level, to increase resources for and concentration on women’s cancers. Efforts need to be cross-sectional not just health-sector focused, include investments in whole health systems, and consider issues of gender equity that prevent women from accessing care. Viewing women’s health in the broader context of the Sustainable Development Goals also will be critical for gaining momentum on women’s cancers.
In low-resource settings, breast and cervical cancer disproportionately affect women in the prime of life, resulting in substantial economic and social effects. A woman’s country, region of residence, income level, socioeconomic status, ethnocultural status, or migration status should no longer affect the likelihood of dying from these common cancers.
The evidence and discussion in the paper series underpins the relevance of organizations like Pink Ribbon Red Ribbon. Pink Ribbon Red Ribbon, an independent affiliate of the George W. Bush Institute, partners with national governments, global NGOs, multilateral institutions, local civil-society, and key leaders to create locally owned, sustainable systems that allow women to access cancer care services. Pink Ribbon Red Ribbon works with its partners across the full continuum of cancer care, from awareness-raising and prevention, through to palliative care. Together with local stakeholders, Government officials, and cancer experts, Pink Ribbon Red Ribbon supports countries to build robust responses to address cervical and breast cancer by coordinating action to provide direct services to women, but also to advance effective policy that ensures viable responses to cervical and breast cancer.
Crystal Cazier serves as Program Manager for the Global Health Initiative and for Evaluation and Research at the George W. Bush Institute. In this role, she helps coordinate the Bush Institute’s involvement in The Partnership to End AIDS and Cervical Cancer, a collaboration of the Bush Institute, PEPFAR, and UNAIDS that works with eight countries in sub-Saharan Africa to prioritize HIV-positive women in national cervical cancer prevention and control programs. She also serves on the research and evaluation team which supports programming across the Bush Institute.
Before joining the Bush Institute, Crystal worked as a Clinical Research Associate at Carle Cancer Center in Urbana, Illinois where she managed budgetary and contractual negotiations for both pharmaceutical and government-sponsored clinical trials.
Crystal received her undergraduate degree from the University of Illinois in Urbana-Champaign and is currently pursuing a Master of Public Health at the University of Texas Health Science Center.Full Bio
Tackling TB and HIV in Women
On World TB Day, we must commit to addressing the dual burden of tuberculosis and HIV affecting hundreds of thousands of women around the world.
A roadmap to fight cervical cancer
The Bush Institute, in partnership with the CDC Foundation, U.S. Centers for Disease Control and Prevention, and the World Health Organization, recently launched a new toolkit to guide countries in the collection and use of cervical cancer data and to enhance the quality, coverage, and scale of interventions against the disease.
Two-Minute Take: World Cancer Day
February 4 is World Cancer Day, an international day to raise awareness about cancer and encourage individual and collective action. At the Bush Institute, we are focused on ensuring that women who are living with HIV do not succumb to cervical cancer.